Loyola Marymount University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Loyola Marymount University sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Loyola Marymount University: 7 sponsored US clinical trials, 2 recruiting.
Loyola Marymount University sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Substance Use, with 1 trials.
Upper-quartile sponsor footprint
Loyola Marymount University sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
NCT07042451
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NCT06191939
Digitally Prompted Parenting: A Text Message Parent-Based Alcohol Intervention for Incoming College Students
NCT06861660
2 College Truths and 1 Lie
NCT06576011
Revolutionizing Normative Re-education
NCT04356261
Parent Feedback Intervention Targeting Student Transitions and Alcohol Related Trajectories (+) Efficacy Study
NCT04549454
A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women
NCT03884478
Therapeutic Areas
What is open in the Loyola Marymount University pipeline
2 recruiting of 7 indexed (29% open); 5 completed (71%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Substance Use (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Loyola Marymount University: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Loyola Marymount University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Loyola Marymount University page
7 registered trials is a research-attention snapshot, not an endorsement of Loyola Marymount University or any single study.
- 2 of Loyola Marymount University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance Use is the condition Loyola Marymount University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Loyola Marymount University pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.